Cargando…
Cellular Mechanisms Underlying the Low Cardiotoxicity of Istaroxime
BACKGROUND: Istaroxime is an inhibitor of Na(+)/K(+) ATPase with proven efficacy to increase cardiac contractility and to accelerate relaxation attributable to a relief in phospholamban‐dependent inhibition of the sarcoplasmic reticulum Ca(2+) ATPase. We have previously shown that pharmacologic Na(+...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483492/ https://www.ncbi.nlm.nih.gov/pubmed/34219467 http://dx.doi.org/10.1161/JAHA.120.018833 |